Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNγ T cell responses in the dog

Vaccine

Volumn 26, Issue 18, 2008, Pages 2186-2190

  Goubier, A ^a   Fuhrmann, L ^a   Forest, L ^a   Cachet, N ^a   Evrad Blanchard, M ^a   Juillard, V ^a   Fischer, L ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Dog; Immune response; Needle free; Plasmid; Route of administration; Vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; PLASMID DNA; PLASMID PNB207; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DOG; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; IMMUNOTHERAPY; NEEDLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, CUTANEOUS; ANIMALS; DOGS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; PLASMIDS; T-LYMPHOCYTES; VACCINES, DNA;

EID: 42249087624     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.059     Document Type: Article

References (50)

1. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
2. Tang D.C., De Vit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 (1992) 152-154
3. Robinson H.L., Hunt L.A., and Webster R.G. Protection against lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 (1993) 957-960
4. Liu M.A., Wahren B., and Hedestam G.B.K. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 17 (2006) 1051-1061
5. Laddy D.J., and Weiner D.B. From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 25 (2006) 99-123
6. Stan R., Wolchok J.D., and Cohen A.D. DNA vaccines against cancer. Hematol Oncol Clin North Am 20 (2006) 613-636
7. Jiang W., Baker H.J., Swango L.J., Schoor J., Self M.J., and Smith B.F. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine 16 (1998) 601-607
8. Gerdts V., JÃns A., Makoschey B., Visser N., and Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol 78 (1997) 2139-2146
9. Somasundaram C., Takamatsu H., Andreoni C., Audonnet J.C., Fischer L., Lefèvre F., et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet Immunol Immunopathol 70 (1999) 277-287
10. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R., et al. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 17 (1999) 1109-1116
11. van Rooij E.M., Haagmans B.L., Glansbeek H.L., de Visser Y.E., de Bruin M.G., Boersma W., et al. A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection. Vet Immunol Immunopathol 74 (2000) 121-136
12. Fischer L., Minke J., Dufay N., Baudu P., and Audonnet J.C. Rabies DNA vaccine in the horse: strategies to improve serological responses. Vaccine 21 (2003) 4593-4596
13. Fischer L., Tronel J.P., Minke J., Barzu S., Baudu P., and Audonnet J.C. Vaccination of puppies with a lipid-formulated plasmid vaccine protects against a severe canine distemper virus challenge. Vaccine 21 (2003) 1099-1102
14. Fischer L., Barzu S., Andreoni C., Buisson N., Brun A., and Audonnet J.C. DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent Pseudorabies virus challenge. Vaccine 21 (2003) 1732-1741
15. Haygreen L., Davison F., and Kaiser P. DNA vaccines for poultry: the jump from theory to practice. Expert Rev Vaccines 4 (2005) 51-62
16. Cupillard L., Juillard V., Latour S., Colombet G., Cachet N., Richard S., et al. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine 23 (2005) 1910-1916
17. Guo A., Jin Z., Zheng Y., Hai G., Yuan G., Li H., et al. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Vaccine 25 (2007) 170-175
18. Fukumoto S., Tamaki Y., Okamura M., Bannai H., Yokoyama N., Suzuki T., et al. Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs. Vaccine 25 (2007) 1334-1341
19. Salonius K., Simard N., Harland R., and Ulmer J.B. The road to licensure of a DNA vaccine. Curr Opin Invest Drugs 8 (2007) 635-641
20. Bachy M., Boudet F., Bureau M., Girerd-Chambaz Y., Wils P., Scherman D., et al. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine 19 (2001) 1688-1693
21. Wu C.J., Lee S.C., Huang H.W., and Tao M.H. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 22 (2004) 1457-1464
22. DobaÃo C., Widera G., Rabussay D., and Doolan D.L. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine 25 (2007) 6635-6645
23. Tsang C., Babiuk S., van Drunen Littel-van den Hurk S., Babiuk L.A., and Griebel P. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 25 (2007) 5485-5494
24. Babiuk S., Tsang C., van Drunen Littel-van den Hurk S., Babiuk L.A., and Griebel P. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry 70 (2007) 269-274
25. Buchan S., Grønevik E., Mathiesen I., King C.A., Stevenson F.K., and Rice J. Electroporation as a 'prime/boost' strategy for naked DNA vaccination against a tumor antigen. J Immunol 174 (2005) 6292-6298
26. Heller L.C., Ugen K., and Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2 (2005) 255-268
27. Capone S., Zampaglione I., Vitelli A., Pezzanera M., Kierstead L., and Burns J. Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates. J Immunol 177 (2006) 7462-7471
28. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., and Roopchand V. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81 (2007) 5257-5269
29. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 (2006) 86-97
30. Ulmer J.B., and Otten G.R. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming. Dev Biol (Basel) 104 (2000) 9-14
31. Brave A., Ljungberg K., Boberg A., Rollman E., Isaguliants M., Lundgren B., et al. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery. Mol Ther 12 (2005) 1197-1205
32. Sheets R.L., Stein J., Manetz T.S., Duffy C., Nason M., Andrews C., et al. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts. Toxicol Sci 91 (2006) 610-619
33. Huang Y., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol 86 (2005) 887-898
34. van Drunen Littel-van den Hurk S., Babiuk S., and Babiuk L.A. Needle-free delivery of veterinary DNA vaccines. Methods Mol Med 127 (2006) 91-105
35. Timmerman J.M., Singh G., Hermanson G., Hobart P., Czerwinski D.K., Taidi B., et al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Cancer Res 62 (2002) 5845-5852
36. Graham B.S., Koup R.A., Roederer M., Bailer R.T., Enama M.E., Moodie Z., et al., Vaccine Research Center 004 Study Team. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis 194 (2006) 1650-1660
37. Tavel J.A., Martin J.E., Kelly G.G., Enama M.E., Shen J.M., Gomez P.L., et al. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects. J Acquir Immune Defic Syndr 44 (2007) 601-605
38. Epstein J.E., Gorak E.J., Charoenvit Y., Wang R., Freydberg N., Osinowo O., et al. Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gene Ther 13 (2002) 1551-1560
39. Aguiar J.C., Hedstrom R.C., Rogers W.O., Charoenvit Y., Sacci Jr. J.B., Lanar D.E., et al. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20 (2001) 275-280
40. Imoto J., and Konishi E. Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model. Viral Immunol 18 (2005) 205-212
41. Hallermalm K., Johansson S., Brave A., Ek M., Engström G., Boberg A., et al. Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer. Scand J Immunol 66 (2007) 43-51
42. Rogers W.O., Baird J.K., Kumar A., Tine J.A., Weiss W., Aguiar J.C., et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect Immun 69 (2001) 5565-5572
43. Bergman P.J., McKnight J., Novosad A., Charney S., Farrelly J., Craft D., et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res 9 (2003) 1284-1290
44. Hartikka J., Sawdey M., and Cornefert-Jensen F. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 7 (1996) 1205-1217
45. Lodmell D.L., Parnell M.J., Weyhrich J.T., and Ewalt L.C. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Vaccine 21 (2003) 3998-4002
46. Lodmell D.L., Ewalt L.C., Parnell M.J., Rupprecht C.E., and Hanlon C.A. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus. Vaccine 24 (2006) 412-416
47. Smith B.F., Baker H.J., Curiel D.T., Jiang W., and Conry R.M. Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen. Gene Ther 5 (1998) 865-868
48. Manam S., Ledwith B.J., Barnum A.B., Troilo P.J., Pauley C.J., Harper L.B., et al. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43 (2000) 273-281
49. Förg P., von Hoegen P., Dalemans W., and Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 5 (1998) 789-797
50. Wolchok J.D., Yuan J., Houghton A.N., Gallardo H.F., Rasalan T.S., Wang J., et al. Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma. Mol Ther 11 (2007) 2044-2050